Comparison of Creatinine and Specific Gravity for Hydration Corrections on Measurement of the Tobacco-Specific Nitrosamine 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol (NNAL) in Urine

被引:17
|
作者
Xia, Yang [1 ]
Wong, Lee-Yang [1 ]
Bunker, Brandon C. [2 ]
Bernert, John T. [1 ]
机构
[1] Ctr Dis Control & Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA
[2] Univ Louisville, Sch Med, Abell Adm Ctr, Louisville, KY 40292 USA
关键词
tobacco-specific nitrosamine; 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL); creatinine; specific gravity; DIETARY-SUPPLEMENT USE; NATIONAL-HEALTH; US POPULATION; SECONDHAND SMOKE; EXPOSURE; VALUES; LUNG; NORMALIZATION; CARCINOGEN; ADJUSTMENT;
D O I
10.1002/jcla.21693
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) was measured in all participants aged 6 years and older from the Centers for Disease Control and Prevention's National Health and Nutrition Examination Survey 2007-2008. The suitability of using creatinine or specific gravity for urinary NNAL correction in exposure assessment is examined in this study. Methods: Effects of both specific gravity and creatinine correction on urinary NNAL among smokers were investigated with multiple linear regression models using either normalization or the fitting of creatinine and specific gravity in the model as covariates. Results: When log-scaled NNAL was normalized by either creatinine or specific gravity, R-2 was slightly higher for creatinine than for specific gravity (R-2 = 0.1694 and 0.1439, for creatinine and specific gravity, respectively). When log-scaled NNAL was normalized by both factors, the R-2 was improved (R-2 = 0.2068). When specific gravity or creatinine was included as a covariate separately in the models, they were highly significant factors (P < 0.001, R-2 = 0.2226 and 0.1681 for creatinine and specific gravity, respectively). However, when both were included in the model as covariates, creatinine remained highly significant (P < 0.001), whereas the significance of specific gravity was eliminated (P = 0.4294). Conclusion: This study confirms significant relationships between NNAL concentrations and both urine creatinine and specific gravity. We conclude that creatinine is the more influential and preferred variable to account for urine dilution in tobacco-specific nitrosamine exposure assessment. (C) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:353 / 363
页数:11
相关论文
共 50 条
  • [21] Smoking Exposure in Early Pregnancy and Adverse Pregnancy Outcomes: Usefulness of Urinary Tobacco-Specific Nitrosamine Metabolite 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol Levels
    Lee, Si Won
    Han, You Jung
    Cho, Dong Hee
    Kwak, Ho-Seok
    Ko, Kinarm
    Park, Mi Hye
    Han, Jung Yeol
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2018, 83 (04) : 365 - 374
  • [22] Pyridylhydroxybutyl and pyridyloxobutyl DNA phosphate adduct formation in rats treated chronically with enantiomers of the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol
    Ma, Bin
    Zarth, Adam T.
    Carlson, Erik S.
    Villalta, Peter W.
    Stepanov, Irina
    Hecht, Stephen S.
    MUTAGENESIS, 2017, 32 (06) : 561 - 570
  • [23] A STUDY OF TOBACCO CARCINOGENESIS - TUMORIGENIC ACTIVITY OF THE TOBACCO-SPECIFIC NITROSAMINES 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE (NNK), 4-(METHYLNITROSAMINO)-4-(3-PYRIDYL)-1-BUTANOL (ISO-NNAL) AND N'-NITROSONORNICOTINE (NNN) ON TOPICAL APPLICATION TO SENCAR MICE
    LAVOIE, EJ
    PROKOPCZYK, G
    RIGOTTY, J
    CZECH, A
    RIVENSON, A
    ADAMS, JD
    CANCER LETTERS, 1987, 37 (03) : 277 - 283
  • [24] Analysis of N- and O-glucuronides of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine
    Carmella, SG
    Le, KA
    Upadhyaya, P
    Hecht, SS
    CHEMICAL RESEARCH IN TOXICOLOGY, 2002, 15 (04) : 545 - 550
  • [25] Combined Analysis of the Tobacco Metabolites Cotinine and 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol in Human Urine
    Kotandeniya, Delshanee
    Carmella, Steven G.
    Ming, Xun
    Murphy, Sharon E.
    Hecht, Stephen S.
    ANALYTICAL CHEMISTRY, 2015, 87 (03) : 1514 - 1517
  • [26] Metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to its biomarker total nnal in smokeless tobacco users
    Hecht, Stephen S.
    Carmella, Steven G.
    Stepanov, Irina
    Jensen, Joni
    Anderson, Amanda
    Hatsukami, Dorothy K.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (03) : 732 - 735
  • [27] Malignant transformation of human bronchial epithelial cells with the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
    Zhou, HN
    Calaf, GM
    Hei, TK
    INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (06) : 821 - 826
  • [28] NICOTINE INHIBITS THE METABOLIC-ACTIVATION OF THE TOBACCO-SPECIFIC NITROSAMINE 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE IN RATS
    RICHTER, E
    TRICKER, AR
    CARCINOGENESIS, 1994, 15 (05) : 1061 - 1064
  • [29] Modulation of the mutagenicity and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by phenolic compounds
    Miller, C
    Castonguay, A
    Teel, RW
    MUTATION RESEARCH-GENETIC TOXICOLOGY, 1996, 368 (3-4): : 221 - 233
  • [30] Acrolein Increases the Pulmonary Tumorigenic Activity of the Tobacco-Specific Nitrosamine 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)
    Peterson, Lisa A.
    Seabloom, Donna
    Smith, William E.
    Vevang, Karin R.
    Seelig, Davis M.
    Zhang, Lin
    Wiedmann, Timothy S.
    CHEMICAL RESEARCH IN TOXICOLOGY, 2022, 35 (10) : 1831 - 1839